Company: BDRX
Filing Date: 2025-05-12
Form Type: 424B3
Source: 0001214659-25-007340
Chunk: 1

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-12
Form: 424B3
Chunk 1
---
 should carefully consider before deciding to purchase these securities.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

<div align='center'>The date of this prospectus is May 9, 2025</div>

<div align='center'>TABLE OF CONTENTS</div>

|                                                      | Page |
| ABOUT THIS PROSPECTUS                                |    1 |
| PRESENTATION OF FINANCIAL AND OTHER INFORMATION      |    2 |
| PROSPECTUS SUMMARY                                   |    4 |
| RISK FACTORS                                         |    9 |
| CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS |   10 |
| USE OF PROCEEDS                                      |   12 |
| DIVIDEND POLICY                                      |   13 |
| CAPITALIZATION                                       |   14 |
| DESCRIPTION OF OFFERED SECURITIES AND SHARE CAPITAL  |   15 |
| DESCRIPTION OF AMERICAN DEPOSITARY SHARES            |   38 |
| TAXATION                                             |   52 |
| SELLING SHAREHOLDERS                                 |   60 |
| PLAN OF DISTRIBUTION                                 |   64 |
| EXPENSES OF THE OFFERING                             |   66 |
| LEGAL MATTERS                                        |   66 |
| EXPERTS                                              |   66 |
| ENFORCEMENT OF CIVIL LIABILITIES                     |   66 |
| WHERE YOU CAN FIND MORE INFORMATION                  |   67 |

| i |

<div align='center'>ABOUT THIS PROSPECTUS</div>

This prospectus is part of a registration statement that we filed with the Securities
and Exchange Commission, or SEC. As permitted by the rules and regulations of the SEC, the registration statement filed by us includes
additional information not contained in this prospectus. You may read the registration statement and the other reports we file with the
SEC at the SEC’s website or its offices described below under the headings “Where You Can Find More Information.”

You should rely only on the
information contained in this prospectus. We have not authorized any person to provide you with information different from that contained
in this prospectus. This prospectus is not an offer to sell, nor is it seeking an offer to buy, these securities in any state where the
offer or sale is not permitted. The information in this prospectus speaks only as of the date of